DeepMed Research

IMPLICIT BIOSCIENCE LIMITED

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Phase 2 Study of IC14 in Acute Respiratory Distress Syndrome

Phase 2

Withdrawn

Conditions: Acute Respiratory Distress Syndrome

Interventions: Drug: IC14
Other: Placebo

First Posted Date: 2017-01-11

Last Posted Date: 2019-03-14

Lead Sponsor: Implicit Bioscience

Registration Number: NCT03017547

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy